June 22, 2022
Assessing Drug-induced Gut Toxicity In Vitro
This webinar addresses the challenges of assessing drug-induced gut toxicity in vitro and introduces the Altis RepliGut Planar Model
May 12, 2022
Altis named one of the top 20 most innovative organ-on-a-chip companies in the world.
Top 20 most innovative organ-on-a-chip companies
February 3, 2022
Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute
Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of human intestinal stem...
January 27, 2022
Altis Biosystems Appoints Jimmy Smedley, Ph.D. Chief Operating Officer
Altis Biosystems appoints Jimmy Smedley, Ph.D., as Chief Operating Officer to lead operations and market strategies for products and services.
October 4-6, 2021
Westin Copley Place & Virtual Event